查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
血液照射市場全球市場:2028年前的預測，COVID-19影響與市場分析:各類型，各適應症，各終端用戶
市場調查報告書
商品編碼
1118299

血液照射市場全球市場:2028年前的預測，COVID-19影響與市場分析:各類型，各適應症，各終端用戶

Blood Irradiation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Indication, and End User
出版日期: | 出版商: The Insight Partners | 英文 170 Pages | 訂單完成後即時交付

價格

全球血液照射的市場規模在2021年估算為6,515萬美金。該市場在2022年～2028年間，預測將以7.0％的年複合成長率擴大，2028年達到1億437萬美元。

本報告提供全球血液照射市場相關調查，提供市場概要，以及各類型，各適應症，各終端用戶，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 簡介

第2章 血液照射市場- 重要點

第3章 調查手法

第4章 血液照射市場-市場形勢

  • PEST分析
  • 專家的見解

第5章 血液照射市場-主要的市場動態

  • 市場促進因素
  • 市場阻礙因素
  • 市場機會
  • 今後趨勢
  • 影響分析

第6章 血液照射市場-世界分析

  • 全球血液照射市場收益預測與分析
  • 企業分析

第7章 血液照射市場分析-各類型

  • 血液照射市場收益佔有率，各類型(2021年及2028年)
  • 靜脈內雷射血液照射
  • 經皮雷射血液照射
  • 體外血液照射

第8章 血液照射市場- 各終端用戶

  • 血液照射市場，各終端用戶(2021年及2028年)(%)
  • 醫院
  • 血庫
  • 診斷中心
  • 研究機關

第9章 血液照射市場- 各適應症

  • 血液照射市場，各適應症(2021年及2028年)(%)
  • 急性白血病
  • 固態腫瘤
  • 骨盆腫瘤
  • 淋巴瘤
  • 其他

第10章 全球血液照射市場-各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 中南美

第11章 COVID-19疫情對全球血液照射市場帶來的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 中南美

第12章 血液照射市場-產業形勢的展望

  • 血液照射市場成長策略，2021年～2028年
  • 無機的成長策略
  • 內部成長策略

第13章 企業簡介

  • Hitachi, Ltd.
  • Best Theratronics Ltd.,
  • Rad Source Technologies
  • Gilardoni S.p.A.
  • Gamma-Service Medical GmbH
  • Typenex Medical
  • Actemium

第14章 附錄

Product Code: TIPRE00003256

The blood irradiation market is projected to reach US$ 104.37 million by 2028 from US$ 65.15 million in 2021; it is expected to grow at a CAGR of 7.0% from 2022 to 2028.

The increase in communicable and noncommunicable diseases prevalence and rise in healthcare expenditure and government initiatives are among the factors driving the market growth. There is an increase in the number of incidence of communicable and noncommunicable diseases, including cancer, cardiovascular disorders, chronic renal disease, and stroke, owing to a large population across the world susceptible to such conditions. According to World Health Organization (WHO), cardiovascular disorders are the leading cause of death globally, and ~17.9 million deaths are reported yearly. Additionally, the rising prevalence of communicable diseases, such as Hepatitis, influenza, Human Immunodeficiency Virus (HIV), and acquired immunodeficiency syndrome (AIDS), are driving the growth of the blood irradiation market. According to WHO, 325 million people were infected with the hepatitis B virus in 2020, and 900,000 people die from hepatitis B virus infection every year. Moreover, a large geriatric population across the world is contributing to the prevalence of noncommunicable diseases, such as cardiovascular disorders, renal disorders, and strokes. According to WHO, the population of people aged 60 years and above was 1 billion in 2019 and is expected to increase to 1.4 billion by 2030 and 2.1 billion by 2050. The elderly population is susceptible to noncommunicable disease conditions owing to various factors such as poor nutrition, lack of physical activity, excessive use of tobacco, and consumption of alcohol.

Additionally, surging blood transfusion owing to an increase in surgical procedures, accidents, trauma cases, and disorders, along with the rising prevalence of bloodstream infections, supports the market growth. Bloodstream infections, underlying conditions, and invasive procedures are common among the geriatric population. Bloodstream infections are the major cause of illness and death among large populations. According to the National Library of Medicine, ~28,000 bloodstream infections occur across the world annually. Moreover, rising awareness about bloodstream infections and increasing immune responses to transfused blood can cause complications as increasing use of irradiated blood in cancer treatment strengthens the immune system and improves overall health of patients, which is driving the growth of the blood irradiation market.

Thus, the increase in prevalence of communicable and noncommunicable disorders, rise in blood transfusion, surge in bloodstream infections, and increase in immune responses are driving the growth of the blood irradiation market.

Increasing immunocompromised population and rising leukemia and lymphoma cases are expected to create ample opportunities for the blood irradiation market in the coming years. According to American Medical Association, in 2021, around 2.7% of the US adult population, ~7 million people, were immunocompromised, due to organ transplants, cancer, and autoimmune disorders. As per the National Institute of Environmental Health Sciences, autoimmune disorders affected more than 24 million population in the US in 2021, and their prevalence rate ranges from 5 to 8%. Additionally, the rising prevalence of cancer and tumors increased the use of chemotherapy and other treatments that negatively affect an individual's immune system. According to World Cancer Research Fund International, 18.1 million cancer cases were diagnosed in 2020, of which 9.3 million were men and 8.8 million were women.

Moreover, there has been significant growth in leukemia and lymphoma incidence rates across the world. According to Leukemia and Lymphoma Society, an estimated total of 186,400 people in the US were diagnosed with leukemia, lymphoma, or myeloma in 2021, and new cases of leukemia, lymphoma, and myeloma are accounted for 9.8% of the estimated 1,898,160 new cancer cases in 2021. Thus, a significant increase in the immunocompromised population and the rising prevalence of autoimmune disorders are expected to create ample opportunities for the blood irradiation market growth in the coming years.

Blood irradiators are a major requirement in the healthcare industry. Hence, researchers have been carrying out research & development activities, which have resulted in product innovations.

For instance, in November 2018, JW Bioscience, a subsidiary of JW Pharmaceutical, launched Sangray developed by Hitachi. Sangray is a medical device used to prevent transfusion-related graft-versus-host disease by irradiating a blood bag for transfusion with X-rays. It is also Korea's first blood radiation device that does not use Cesium-137, which is a hazardous radioactive substance.

There have been advancements in alternative technologies, such as proton and ion beam therapies, that use high-energy, positive ions and have high precision in treating tumors with reduced exposure to normal tissues. Moreover, FLASH radiotherapy, carbon ion therapy, volumetric-modulated arc therapy, and intensity-modulated radiotherapy treat solid tumors. These technological advancements and developments have a high precision rate with reduced side effects, likely to create ample opportunities for the blood irradiation market in the coming years. Thus, an increase in technological advancements, rise in product launches, and the surge in the use of alternative technologies are expected to support the growth of the market in the coming years..

Further, rising partnerships and collaborations of blood centers and huge companies drive the growth of the blood irradiators market.

Geography-Based Insights

North America held the largest share of the blood irradiation market in 2021. The US held the largest market share in North America. Advanced healthcare infrastructure, easy accessibility to medical facilities, and rising emphasis on improving treatment outcomes are expected to accelerate the growth of the market during the forecast period.

Asia Pacific is expected to witness the highest growth in the global blood irradiation market during the forecast period. In the coming years, the market is the region is expected to grow significantly in China, Japan, India, and other countries. The market is driven by growing investments from international players in China and India, improving government support in countries such as China, and advancing healthcare infrastructure. Therefore, the region would hold huge potential for the blood irradiation market players to grow during the forecast period.

Type-Based Insights

The blood irradiation market, based on type, is segmented into intravenous laser blood irradiation , transcutaneous laser blood irradiation,and extracorporeal blood irradiation. In 2021, the intravenous laser blood irradiation segment accounted for the largest market share. However, the extracorporeal laser blood irradiation segment is expected to register the highest CAGR of 7.8% during the forecast period.

End User-Based Insights

Based on end user, the blood irradiation market is segmented into hospitals, blood banks, diagnostics clinics, and research institutes. The hospitals segment held the largest market share in 2021. However, the blood banks segment is estimated to register the highest CAGR of 7.7% in the market during the forecast period.

Indication-Based Insights

By indication, the blood irradiation market is segmented into acute leukemia, solid tumors, pelvic tumors, lymphoma, and others. The acute leukemia segment held the largest market share in 2021. However, the lymphoma segment is estimated to register the highest CAGR of 8.8% in the market during the forecast period.

.

The World Health Organization (WHO), Globocan, World Bank Data, National Health Service (NHS), National Library of Medicine (NLM), and Eurostat are a few secondary sources referred to while preparing the report on the blood irradiation market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the blood irradiation market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global blood irradiation market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Blood Irradiation Market - By Type
    • 1.3.2 Global Blood Irradiation Market - By Indication
    • 1.3.3 Global Blood Irradiation Market - By End User
    • 1.3.4 Global Blood Irradiation Market - By Geography

2. Blood Irradiation Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Blood Irradiation Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East And Africa PEST Analysis
    • 4.2.5 South And Central America PEST Analysis
  • 4.3 Experts Opinion

5. Blood Irradiation Market- Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increase in Communicable and Noncommunicable Diseases
    • 5.1.2 Rise in Healthcare Expenditure and Government Initiatives
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Policies, High Cost, and Challenges with Blood Component Irradiation
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Immunocompromised Population and Rising Incidences of Leukemia And Lymphoma
  • 5.4 Future Trends
    • 5.4.1 Technological Advancements And Product Launches
  • 5.5 Impact Analysis

6. Blood Irradiation Market- Global Analysis

  • 6.1 Global Blood Irradiation Market Revenue Forecasts and Analysis
    • 6.1.1 Overview
    • 6.1.2 Global Blood Irradiation Market, and Forecast to 2028 (Units)
    • 6.1.3 Global Blood Irradiation Market, By Geography - Forecasts and Analysis
    • 6.1.4 Global Blood Irradiation Market - Market Potential Analysis, By Region
  • 6.2 Company Analysis
    • 6.2.1 Market Positioning of Key Players
    • 6.2.2 Comparative Company Analysis
    • 6.2.3 Growth Strategy Analysis
    • 6.2.4 Performance Of Key Players
    • 6.2.5 Hitachi Medical Systems
    • 6.2.6 Best Theratronics

7. Blood Irradiation Market Analysis - By Type

  • 7.1 Overview
  • 7.2 Blood Irradiation Market Revenue Share, by Type (2021 and 2028)
  • 7.3 Intravenous Laser Blood Radiation
    • 7.3.1 Overview
    • 7.3.2 Intravenous Laser Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Transcutaneous Laser Blood Radiation
    • 7.4.1 Overview
    • 7.4.2 Transcutaneous Laser Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Extracorporeal Blood Radiation
    • 7.5.1 Overview
    • 7.5.2 Extracorporeal Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)

8. Blood Irradiation Market -By End User

  • 8.1 Overview
  • 8.2 Blood Irradiation Market, by End User, 2021 and 2028 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Blood Banks
    • 8.4.1 Overview
    • 8.4.2 Blood Banks: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Diagnostic Centers
    • 8.5.1 Overview
    • 8.5.2 Diagnostic Centers: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Research Institutes
    • 8.6.1 Overview
    • 8.6.2 Research Institutes: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)

9. Blood Irradiation Market -By Indication

  • 9.1 Overview
  • 9.2 Blood Irradiation Market, by Indication, 2021 and 2028 (%)
  • 9.3 Acute Leukemia
    • 9.3.1 Overview
    • 9.3.2 Acute Leukemia: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Solid Tumors
    • 9.4.1 Overview
    • 9.4.2 Solid Tumors: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Pelvic Tumors
    • 9.5.1 Overview
    • 9.5.2 Pelvic Tumors: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Lymphoma
    • 9.6.1 Overview
    • 9.6.2 Lymphoma: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)

10. Global Blood Irradiation Market - Geographic Analysis

  • 10.1 North America: Blood Irradiation Market
    • 10.1.1 Overview
    • 10.1.2 North America: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    • 10.1.4 North America: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    • 10.1.5 North America: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
    • 10.1.6 North America: Blood Irradiation Market, by Country, 2021 & 2028 (%)
      • 10.1.6.1 US: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.3 US: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.1.6.1.4 US: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.1.6.1.5 US: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.1.6.2 Canada: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.3 Canada: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.1.6.2.4 Canada: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.1.6.2.5 Canada: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.1.6.3 Mexico: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.3 Mexico: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.1.6.3.4 Mexico: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.1.6.3.5 Mexico: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
  • 10.2 Europe: Blood Irradiation Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    • 10.2.4 Europe: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    • 10.2.5 Europe: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
    • 10.2.6 Europe: Blood Irradiation Market, by Country, 2021 & 2028 (%)
      • 10.2.6.1 Germany: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 Germany: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.1.4 Germany: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.2.6.1.5 Germany: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.2.6.2 UK: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 UK: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 UK: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.2.4 UK: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.2.6.2.5 UK: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.2.6.3 France: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 France: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 France: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.3.4 France: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.2.6.3.5 France: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.2.6.4 Italy: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.4.4 Italy: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.2.6.4.5 Italy: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.2.6.5 Spain: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.5.4 Spain: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.2.6.5.5 Spain: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.2.6.6 Rest of Europe: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
  • 10.3 Asia Pacific: Blood Irradiation Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    • 10.3.5 Asia Pacific: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
    • 10.3.6 Asia Pacific: Blood Irradiation Market, by Country, 2021 & 2028 (%)
      • 10.3.6.1 China Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.3 China: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.1.4 China: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.3.6.1.5 China: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.3.6.2 Japan Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.3 Japan: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.2.4 Japan: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.3.6.2.5 Japan: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.3.6.3 India Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.3 India: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.3.4 India: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.3.6.3.5 India: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.3.6.4 South Korea Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 South Korea: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.4.4 South Korea: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.3.6.4.5 South Korea: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.3.6.5 Australia Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 Australia: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.3 Australia: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.5.4 Australia: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.3.6.5.5 Australia: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
  • 10.4 Middle East & Africa Blood Irradiation Market Revenue and Forecasts To 2028
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 Middle East & Africa: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    • 10.4.4 Middle East & Africa Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.5 Middle East & Africa Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.6 Middle East & Africa: Blood Irradiation Market, by Country, 2021 & 2028 (%)
      • 10.4.6.1 Saudi Arabia: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.1 Overview
        • 10.4.6.1.2 Saudi Arabia: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.3 Saudi Arabia: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.4.6.1.4 Saudi Arabia Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.5 Saudi Arabia Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.2 UAE: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.1 Overview
        • 10.4.6.2.2 UAE: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.3 UAE: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.4.6.2.4 UAE Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.5 UAE Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.3 South Africa: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.1 Overview
        • 10.4.6.3.2 South Africa: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.3 South Africa: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.4.6.3.4 South Africa Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.5 South Africa Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.4 Rest of Middle East & Africa: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.4.1 Overview
        • 10.4.6.4.2 Rest of Middle East & Africa: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.4.3 Rest of Middle East & Africa: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.4.6.4.5 Rest of Middle East & Africa: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
  • 10.5 South and Central America Blood Irradiation Market Revenue and Forecasts To 2028
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.3 South and Central America: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    • 10.5.4 South and Central America: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    • 10.5.5 South and Central America: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
    • 10.5.6 South and Central America: Blood Irradiation Market, by Country, 2021 & 2028 (%)
      • 10.5.6.1 Brazil: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 Brazil: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.3 Brazil: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.5.6.1.4 Brazil: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.5.6.1.5 Brazil: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.5.6.2 Argentina: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Argentina: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.3 Argentina: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.5.6.2.4 Argentina: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.5.6.2.5 Argentina: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
      • 10.5.6.3 Rest of South and Central America: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 Rest of South and Central America: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.3 Rest of South and Central America: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
        • 10.5.6.3.4 Rest of South and Central America: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
        • 10.5.6.3.5 Rest of South and Central America: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)

11. Impact of COVID-19 Pandemic on Global Blood Irradiation Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Blood Irradiation Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Blood Irradiation Market, 2021-2028
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Hitachi, Ltd.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Best Theratronics Ltd.,
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Rad Source Technologies
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Gilardoni S.p.A.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Gamma-Service Medical GmbH
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Typenex Medical
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Actemium
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Global Blood Irradiation Market- Volume and Forecast to 2028 (Units)
  • Table 2. North America Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America: Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Mexico Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Europe Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Europe: Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Europe Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Germany Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Germany: Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Germany Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. UK Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. UK: Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. UK Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. France Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. France: Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. France Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Italy Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Italy: Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Italy Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Rest of Europe Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe: Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Asia Pacific Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Asia Pacific: Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Asia Pacific Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. China Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. China Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. China Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Japan Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Japan Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Japan Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. India Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. India Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. India Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. South Korea Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. South Korea Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. South Korea Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Australia Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Australia Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Australia Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Rest of Asia Pacific Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Asia Pacific Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Asia Pacific Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Middle East & Africa Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. Middle East & Africa Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. Middle East & Africa Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Saudi Arabia Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Saudi Arabia Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 60. Saudi Arabia Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. UAE Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. UAE Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 63. UAE Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. South Africa Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. South Africa Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 66. South Africa Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Rest of Middle East & Africa Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Rest of Middle East & Africa Blood Irradiation Market, by End-Users- Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Rest of Middle East & Africa Blood Irradiation Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. South and Central America: Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. South and Central America: Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. South and Central America: Blood Irradiation Market, by Indication- Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Brazil: Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Brazil: Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Brazil: Blood Irradiation Market, by Indication- Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Argentina: Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. Argentina: Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. Argentina: Blood Irradiation Market, by Indication- Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Rest of South and Central America: Blood Irradiation Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Rest of South and Central America: Blood Irradiation Market, by End-Users - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Rest of South and Central America: Blood Irradiation Market, by Indication- Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Recent Inorganic Growth Strategies in the Blood Irradiation Market
  • Table 83. Recent Organic Growth Strategies in the Blood Irradiation Market
  • Table 84. Glossary of Terms, Blood Irradiation Market

List Of Figures

  • Figure 1. Blood Irradiation Market Segmentation
  • Figure 2. Blood Irradiation Market Segmentation, By Region
  • Figure 3. Global Blood Irradiation Market Overview
  • Figure 4. Intravenous Laser Blood Irradiation Segment Held Largest Share of Type Segment in Blood Irradiation Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Blood Irradiation Market, by Geography (US$ Million)
  • Figure 7. Global Blood Irradiation Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Blood Irradiation Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East And Africa: PEST Analysis
  • Figure 13. South And Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Blood Irradiation Market Impact Analysis of Drivers and Restraints
  • Figure 16. Global Blood Irradiation Market - Revenue Forecasts and Analysis - 2020- 2028
  • Figure 17. Global Blood Irradiation Market - By Geography Forecasts and Analysis - 2021- 2028
  • Figure 18. Global Blood Irradiation Market - Market Potential Analysis, By Region
  • Figure 19. Market Positioning of Key Players In Global Blood Irradiation Market
  • Figure 20. Global Blood Irradiation Market - Comparative Company Analysis
  • Figure 21. Global Blood Irradiation Market - Growth Strategy Analysis
  • Figure 22. Blood Irradiation Market Revenue Share, by Type (2021 and 2028)
  • Figure 23. Intravenous Laser Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Transcutaneous Laser Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Extracorporeal Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Blood Irradiation Market, by End User, 2021 and 2028 (%)
  • Figure 27. Hospitals: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Blood Banks: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Diagnostic Centers: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Research Institutes: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Blood Irradiation Market, by Indication, 2021 and 2028 (%)
  • Figure 32. Acute Leukemia: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Solid Tumors: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Pelvic Tumors: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Lymphoma: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Others: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. North America: Blood Irradiation Market, by Key Country - Revenue (2021) (US$ 'Million)
  • Figure 38. North America Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. North America: Blood Irradiation Market, by Country, 2021 & 2028 (%)
  • Figure 40. US: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Canada: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Mexico: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Europe: Blood Irradiation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 44. Europe Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Europe: Blood Irradiation Market, by Country, 2021 & 2028 (%)
  • Figure 46. Germany: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. UK: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. France: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Italy: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Spain: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Rest of Europe: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Asia Pacific: Blood Irradiation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 53. Asia Pacific Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Asia Pacific: Blood Irradiation Market, by Country, 2021 & 2028 (%)
  • Figure 55. China: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. Japan: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. India: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. South Korea: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Australia: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. Rest of Asia Pacific: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. Middle East & Africa: Blood Irradiation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 62. Middle East & Africa Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Middle East & Africa: Blood Irradiation Market, by Country, 2021 & 2028 (%)
  • Figure 64. Saudi Arabia: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. UAE: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. South Africa: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. Rest of Middle East & Africa: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. South and Central America: Blood Irradiation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 69. South and Central America Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. South and Central America: Blood Irradiation Market, by Country, 2021 & 2028 (%)
  • Figure 71. Brazil: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 72. Argentina: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 73. Rest of South and Central America: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 74. Impact Of COVID-19 Pandemic in North American Country Markets
  • Figure 75. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 76. Impact of COVID-19 Pandemic in Asia Pacific Countries
  • Figure 77. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 78. Impact of COVID-19 Pandemic in South and Central American Countries
  • Figure 79. Growth Strategies in the Blood Irradiation Market, 2021-2028